Correlation of Culture Positivity, PCR Positivity, and Burden of Borrelia burgdorferi Sensu Lato in Skin Samples of Erythema Migrans Patients with Clinical Findings.

PubWeight™: 0.78‹?›

🔗 View Article (PMC 4564201)

Published in PLoS One on September 09, 2015

Authors

Daša Stupica1, Lara Lusa2, Vera Maraspin1, Petra Bogovič1, Darja Vidmar1, Maria O'Rourke3, Andreas Traweger3, Ian Livey3, Franc Strle1

Author Affiliations

1: Department of Infectious Diseases, University Medical Center Ljubljana, Ljubljana, Slovenia.
2: Institute for Biostatistics and Medical Informatics, Faculty of Medicine, Ljubljana, Slovenia.
3: Vaccine R & D, Baxter Innovations, Orth an der Donau, A-2304, Austria.

Articles cited by this

Lyme disease. N Engl J Med (2001) 7.29

The early clinical manifestations of Lyme disease. Ann Intern Med (1983) 5.73

Duration of antibiotic therapy for early Lyme disease. A randomized, double-blind, placebo-controlled trial. Ann Intern Med (2003) 3.96

Lyme borreliosis. Lancet (2003) 3.75

Elevated levels of IL-23 in a subset of patients with post-lyme disease symptoms following erythema migrans. Clin Infect Dis (2013) 3.36

Subjective symptoms after treatment of early Lyme disease. Am J Med (2010) 3.22

Treatment of the early manifestations of Lyme disease. Ann Intern Med (1983) 2.89

Azithromycin compared with amoxicillin in the treatment of erythema migrans. A double-blind, randomized, controlled trial. Ann Intern Med (1996) 2.58

Lyme borreliosis: clinical case definitions for diagnosis and management in Europe. Clin Microbiol Infect (2011) 2.23

Treatment of early Lyme disease. Am J Med (1992) 2.18

Long-term follow-up of patients with culture-confirmed Lyme disease. Am J Med (2003) 1.62

Burden and viability of Borrelia burgdorferi in skin and joints of patients with erythema migrans or lyme arthritis. Arthritis Rheum (2011) 1.44

Amoxycillin plus probenecid versus doxycycline for treatment of erythema migrans borreliosis. Lancet (1990) 1.41

Quantitative detection of Borrelia burgdorferi in 2-millimeter skin samples of erythema migrans lesions: correlation of results with clinical and laboratory findings. J Clin Microbiol (2002) 1.40

Treatment of erythema migrans with doxycycline for 10 days versus 15 days. Clin Infect Dis (2012) 1.05

Quantitative detection of Borrelia burgdorferi sensu lato in erythema migrans skin lesions using internally controlled duplex real time PCR. PLoS One (2013) 1.02

Comparison of cefuroxime axetil and doxycycline in treatment of patients with early Lyme disease associated with erythema migrans. Antimicrob Agents Chemother (1995) 1.02

A new approach to a Lyme disease vaccine. Clin Infect Dis (2011) 0.96

Azithromycin versus penicillin V for the treatment of early Lyme borreliosis. Infection (1994) 0.93

Comparison of post-Lyme Borreliosis symptoms in erythema migrans patients with positive and negative Borrelia burgdorferi sensu lato skin culture. Vector Borne Zoonotic Dis (2010) 0.91

Genotypic and phenotypic characterisation of Borrelia burgdorferi sensu lato strains isolated from human blood. J Med Microbiol (2001) 0.87

A randomized trial of ceftriaxone versus oral penicillin for the treatment of early European Lyme borreliosis. Infection (1990) 0.86

Clinical features of early erythema migrans disease and related disorders. Zentralbl Bakteriol Mikrobiol Hyg A (1986) 0.78